Coste Mazeau, P.; Jacquet, C.; Muller, C.; Courant, M.; El Hamel, C.; Chianea, T.; Hantz, S.; Alain, S.
Potential of Anti-CMV Immunoglobulin Cytotect CP® In Vitro and Ex Vivo in a First-Trimester Placenta Model. Microorganisms 2022, 10, 694.
https://doi.org/10.3390/microorganisms10040694
AMA Style
Coste Mazeau P, Jacquet C, Muller C, Courant M, El Hamel C, Chianea T, Hantz S, Alain S.
Potential of Anti-CMV Immunoglobulin Cytotect CP® In Vitro and Ex Vivo in a First-Trimester Placenta Model. Microorganisms. 2022; 10(4):694.
https://doi.org/10.3390/microorganisms10040694
Chicago/Turabian Style
Coste Mazeau, Perrine, Chloé Jacquet, Clotilde Muller, Mathis Courant, Chahrazed El Hamel, Thierry Chianea, Sébastien Hantz, and Sophie Alain.
2022. "Potential of Anti-CMV Immunoglobulin Cytotect CP® In Vitro and Ex Vivo in a First-Trimester Placenta Model" Microorganisms 10, no. 4: 694.
https://doi.org/10.3390/microorganisms10040694
APA Style
Coste Mazeau, P., Jacquet, C., Muller, C., Courant, M., El Hamel, C., Chianea, T., Hantz, S., & Alain, S.
(2022). Potential of Anti-CMV Immunoglobulin Cytotect CP® In Vitro and Ex Vivo in a First-Trimester Placenta Model. Microorganisms, 10(4), 694.
https://doi.org/10.3390/microorganisms10040694
